(VICL:Consolidated Issue Listed on NASDAQ Global Select )
Vijay B. Samant
Chief Executive Officer, President, Acting Chief Financial Officer and Director, Vical Incorporated
|Age||Total Calculated Compensation||This person is connected to 15 board members in 2 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Vijay B. Samant has been the Chief Executive Officer of Vical Incorporated since 1990 and has been its President since November 2000. Mr. Samant joined Vical Inc. in November 2000 and has been its Acting Chief Financial Officer since April 12, 2013. He has over 23 years of U.S. and International Pharmaceuticals experience in the areas of Sales, Marketing, Operations and Business Development. Previously, Mr. Samant held various positions at Merck & Co., Inc. from ...
10390 Pacific Center CourtPhone: 858-646-1100
San Diego, California 92121
Board Members Memberships*
Chief Executive Officer, President, Acting Chief Financial Officer and Director
Former Director, Member of Compensation Committee and Member of Corporate Governance & Nominating Committee
MIT Sloan School of Management
University of Mumbai
University Department of Chemical Technology India
|J. Joseph Kim Ph.D.||Chief Executive Officer, President, Director and Member of Finance Committee|
Inovio Pharmaceuticals, Inc.
|Douglas J. Swirsky CPA, CFA||Chief Executive Officer, President, Corporate Secretary and Director|
|Jeffrey D. Abbey MBA, J.D.||Chief Executive Officer, President and Director|
Argos Therapeutics, Inc.
|Steven W. King||Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc|
Peregrine Pharmaceuticals, Inc.
|Eddie Gray||Chief Executive Officer and Director|
Dynavax Technologies Corporation
|$515.0K||Compensation as of Fiscal Year 2014.|